Skip to main content
. 2019 Feb 28;35(3):310–325. doi: 10.1089/aid.2018.0180

Table 1.

Vaccination Groups and Schedule

Group Prime (weeks 0 and 3) Dose and route Boost (weeks 6 and 9) Dose and route First oral SIVmac251 exposure
A (n = 6) Saline 1 mL O + 0.25 mL IM Empty MVA 108 PFU SL + 108 PFU IM Week 12
B (n = 6) DNA-SIVa 3.0 mg IMb MVA-SIV 108 PFU IM Week 12
C (n = 6) DNA-SIV 1.5 mg O + 1.5 mg IMc MVA-SIV 108 PFU SL + 108 PFU IM Week 12
a

DNA-SIV: 1:1 mixture of DG + D40L.

b

1.5 mg DG + 1.5 mg D40L.

c

0.75 mg DG + 0.75 mg D40L by each route.

SIV, simian immunodeficiency virus; O, oral; IM, intramuscular; SL, sublingual; MVA, modified vaccinia Ankara; PFU, plaque forming units.